查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2148908

眼內植入市場規模、佔有率、成長、全球產業分析、區域趨勢及2026年至2034年預測

Ocular Implants Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

眼內植入市場的成長要素

2025年全球眼內植入市場規模為168億美元。預計該市場將從2026年的179.6億美元成長至2034年的306.4億美元，2026年至2034年的複合年成長率（CAGR）為6.90%。截至2025年，北美佔據34.25%的市場佔有率，是推動全球眼科植入市場成長的主要力量。人們對眼科疾病的認知不斷提高、眼科診斷技術的進步以及治療方案資訊的獲取管道日益豐富，都促進了先進眼科植入的應用。

本市場涵蓋人工水晶體、青光眼植入、義眼、角膜植入及其他植入式眼科器械。白內障和青光眼盛行率的上升、技術創新以及眼科手術覆蓋範圍的擴大預計將推動市場成長。

市場趨勢

眼科植入市場的主要趨勢之一是技術先進的義眼日益普及。數位技術的進步使得製造能夠更精確、更快速地忠實再現自然眼外觀的人工眼成為可能。為了滿足功能和美觀的雙重需求，玻璃、壓克力和鞏膜殼式義眼正持續發展。

另一個重要趨勢是微創青光眼手術器械和先進人工水晶體的日益普及。患者意識的提高和先進眼科手術的普及，促使患者尋求使用最新植入進行治療。

市場促進因素

白內障和青光眼發生率上升：

白內障、青光眼、屈光不正和其他眼科疾病的負擔日益加重，尤其是在老年族群中，這推動了對人工植入的需求。白內障在亞洲，包括中國、印度和日本等地的發病率尤其高，這為人工水晶體製造商創造了巨大的商機。

技術進步：

仿生視覺系統、微創青光眼治療設備、先進的人工水晶體和角膜植入等領域的創新正在拓展治療選擇。無線視網膜下植入等新興技術也為重度視力喪失患者創造了新的可能性。

市場限制與挑戰

嚴格的監管批准和產品召回：

眼內植入需要嚴格的監管評估，因為併發症會直接影響視力和眼睛健康。漫長的核准流程可能會延遲產品上市。此外，產品召回和安全問題會削弱患者和醫生的信心。開發中國家獲得先進眼科醫療服務的機會有限仍然是一項重大挑戰。

細分分析

依產品類型：

此市場細分包括人工水晶體、青光眼植入、義眼、角膜植入及其他產品。預計到2025年，人工水晶體將成為市場成長的主要驅動力，佔據66.6%的市場佔有率，這主要得益於白內障盛行率的上升、技術的進步以及應用範圍的擴大。由於微創青光眼手術器械的日益普及，青光眼植入預計也將強勁成長。

按最終用戶分類：

市場細分為醫院、眼科診所和其他機構。由於眼科手術數量的增加和先進醫療基礎設施的建設，醫院在市場中佔據主導地位。預計到2025年，醫院領域的收入將達到37.676億美元。

區域分析

由於先進的眼內植入的高滲透率、有利的報銷政策、完善的醫療基礎設施以及主要市場參與者的強大影響力，預計到 2025 年，北美將以 34.25% 的市場佔有率主導全球市場。

根據這項研究，歐洲預計將保持穩定成長，預測期內複合年成長率（CAGR）預計為5.3%。德國、法國和英國等國家對技術先進的眼科醫療設備的日益普及，支撐了該地區的需求。

由於人口老化、白內障和青光眼高發以及眼科治療服務可近性的提高，亞太地區預計將成為成長最快的市場。預計到2025年，日本人工水晶體市場規模將達到4.421億美元，而印度在預測期內的複合年成長率預計將達到7.70%。

拉丁美洲、中東和非洲目前市場佔有率相對較小，但隨著醫療基礎設施和治療機會的改善，未來可望迎來更多機會。

目錄

第1章：引言

第2章執行摘要

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機遇

第4章：主要考慮因素

  • 主要眼科疾病的流行病學：聚焦主要國家
  • 產業重大發展：合併、收購與合作。
  • 主要國家和地區監管狀況概述
  • 眼內植入產業的新產品引進/核准情況
  • 全球眼科手術器械市場概覽

第5章：全球眼內植入市場分析、洞察與預測（2021-2034年）

  • 主要發現與總結
  • 市場分析、洞察與預測：按產品類型分類
    • 人工水晶體
    • 青光眼植入
    • 眼假體
    • 角膜植入和其他
  • 市場分析、洞察與預測：按最終用戶分類
    • 醫院
    • 眼科診所
    • 其他
  • 市場分析、洞察與預測：按國家/地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第6章：北美眼內植入市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章：歐洲眼內植入市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪地那維亞
    • 其他歐洲國家

第8章：亞太地區眼內植入市場分析、洞察與預測（2021-2034年）

  • 國家
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家

第9章：拉丁美洲眼內植入市場分析、洞察與預測（2021-2034年）

  • 國家
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家

第10章：中東和非洲眼內植入市場分析、洞察與預測（2021-2034年）

  • 國家
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲國家

第11章 競爭分析

  • 主要行業趨勢
  • 全球市佔率分析（2025 年）
  • 競爭對手儀錶板
  • 主要公司比較分析
  • 公司簡介
    • Alcon
    • Johnson and Johnson Services, Inc.
    • Bausch & Lomb Incorporated
    • ZEISS International
    • STAAR SURGICAL
    • Hoya Corporation
    • Glaukos
    • Second Sight
    • Allergan
    • Other Prominent Players

第12章 戰略建議

Product Code: FBI101877

Growth Factors of ocular implants Market

The global ocular implants market size was valued at USD 16.80 billion in 2025. The market is projected to grow from USD 17.96 billion in 2026 to USD 30.64 billion by 2034, registering a CAGR of 6.90% during 2026-2034. North America dominated the global ocular implants market with a 34.25% market share in 2025. Increasing awareness of ocular diseases, improved ophthalmic diagnostics, and greater accessibility to information about treatment options are supporting the adoption of advanced ocular implants.

The market includes intraocular lenses, glaucoma implants, ocular prostheses, corneal implants, and other implantable ophthalmic devices. Rising cataract and glaucoma prevalence, technological innovation, and increasing access to ophthalmic surgery are expected to strengthen market growth.

Market Trends

A significant ocular implants market trend is the increasing adoption of technologically advanced ocular prostheses. Improvements in digital technology are enabling more precise and faster construction of artificial eyes that closely replicate the appearance of natural eyes. Glass, acrylic, and scleral-shell prostheses are increasingly being developed to address both functional and aesthetic requirements.

Another important trend is the growing adoption of microinvasive glaucoma surgery devices and advanced intraocular lenses. Increasing patient awareness and the availability of sophisticated ophthalmic procedures are encouraging patients to seek modern implant-based treatments.

Market Drivers

Increasing Prevalence of Cataract and Glaucoma:

The rising burden of cataract, glaucoma, refractive errors, and other ocular disorders, particularly among the aging population, is driving demand for ocular implants. Cataract prevalence is particularly significant across Asia, including China, India, and Japan, creating substantial opportunities for intraocular lens manufacturers.

Technological Advancements:

Innovations in bionic vision systems, microinvasive glaucoma devices, advanced intraocular lenses, and corneal implants are improving treatment options. Emerging technologies such as wireless sub-retinal implants are also creating new possibilities for patients with severe vision loss.

Market Restraints and Challenges

Stringent Regulatory Approvals and Product Recalls:

Ocular implants require rigorous regulatory evaluation because complications can directly affect vision and eye health. Lengthy approval procedures can delay product commercialization. Product recalls and safety concerns can also reduce patient and physician confidence. Limited access to advanced ophthalmic treatment in underdeveloped countries remains another important challenge.

Segmentation Analysis

By Product Type:

The market is segmented into intraocular lenses, glaucoma implants, ocular prosthesis, corneal implants, and others. Intraocular lenses dominated the market with a 66.6% share in 2025, supported by the increasing prevalence of cataracts, technological advancements, and wider accessibility. Glaucoma implants are also expected to experience healthy growth due to increasing adoption of microinvasive glaucoma surgery devices.

By End User:

The market is categorized into hospitals, ophthalmic clinics, and others. Hospitals held the dominant market position, supported by the increasing number of ophthalmic surgeries and availability of advanced healthcare infrastructure. The hospital segment is projected to generate USD 3,767.6 million in revenue by 2025.

Regional Analysis

North America dominated the global market with a 34.25% share in 2025, supported by high adoption of advanced ocular implants, favorable reimbursement policies, established healthcare infrastructure, and strong presence of leading market players.

Europe is expected to maintain steady growth, with the source indicating a 5.3% CAGR during the forecast period. Increasing adoption of technologically advanced ophthalmic devices in countries such as Germany, France, and the U.K. is supporting regional demand.

Asia Pacific is anticipated to register the fastest growth due to the increasing geriatric population, high prevalence of cataracts and glaucoma, and improving accessibility to ophthalmic treatments. Japan's ocular implants market is expected to reach USD 442.1 million by 2025, while India is projected to register a 7.70% CAGR during the forecast period.

Latin America and the Middle East & Africa currently account for comparatively smaller shares but offer future opportunities as healthcare infrastructure and treatment accessibility improve.

Key Industry Players

Major companies in the ocular implants market include Alcon, Johnson and Johnson Services, Inc., Bausch & Lomb Incorporated, ZEISS International, STAAR SURGICAL, Hoya Corporation, Glaukos, Second Sight, and Allergan. Alcon and Johnson & Johnson maintain strong competitive positions through their extensive intraocular lens portfolios and ophthalmic device offerings.

Recent Industry Developments

In January 2018, Glaukos submitted an IDE application to the U.S. FDA for its iStent infinite glaucoma treatment device. In March 2019, Novartis announced the spin-off of ownership of Alcon, marking its exit from the eye-care industry.

Future Outlook

The ocular implants market outlook remains positive through 2034. The market is expected to expand from USD 16.80 billion in 2025 to USD 17.96 billion in 2026 and USD 30.64 billion by 2034. Increasing cataract and glaucoma prevalence, rising awareness, technological innovation, and growing ophthalmic surgery volumes are expected to create sustained opportunities. Asia Pacific is likely to remain an important growth region, while North America continues to benefit from advanced healthcare infrastructure and strong adoption of innovative devices.

Conclusion

The global ocular implants market is positioned for steady expansion as the prevalence of eye disorders increases and patients gain greater access to advanced ophthalmic treatments. Intraocular lenses remain the dominant product category, while glaucoma implants, ocular prostheses, and emerging technologies are creating additional opportunities. Although stringent regulations, product safety concerns, and limited accessibility in developing markets remain challenges, continued technological advancements and increasing demand for effective vision-restoration solutions are expected to support market growth through 2034.

Unit Value (USD billion)

Segmentation By Product Type

  • Intraocular Lens
  • Glaucoma Implants
  • Ocular Prostheses
  • Corneal Implants and Others

By End-user

  • Hospitals
  • Ophthalmic Clinics
  • Others

By Geography

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  • Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities

4. Key Insights

  • 4.1. Epidemiology of Key Ocular Disorder - for Key Countries
  • 4.2. Key Industry Developments - Mergers, Acquisitions, and Partnerships
  • 4.3. Overview of Regulatory Scenario in Key Countries/ Regions
  • 4.4. Introduction of New Products/ Approvals in Ocular Implant Industry
  • 4.5. Snapshot of Global Ophthalmic Surgery Devices Market

5. Global Ocular Implants Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Key Findings / Summary
  • 5.2. Market Analysis, Insights and Forecast - By Product Type
    • 5.2.1. Intraocular Lens
    • 5.2.2. Glaucoma Implants
    • 5.2.3. Ocular Prostheses
    • 5.2.4. Corneal Implants and Others
  • 5.3. Market Analysis, Insights and Forecast - By End-user
    • 5.3.1. Hospitals
    • 5.3.2. Ophthalmic Clinics
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Country
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Ocular Implants Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Key Findings / Summary
  • 6.2. Market Analysis - By Product Type
    • 6.2.1. Intraocular Lens
    • 6.2.2. Glaucoma Implants
    • 6.2.3. Ocular Prostheses
    • 6.2.4. Corneal Implants and Others
  • 6.3. Market Analysis - By End-user
    • 6.3.1. Hospitals
    • 6.3.2. Ophthalmic Clinics
    • 6.3.3. Others
  • 6.4. Market Analysis - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Ocular Implants Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Key Findings / Summary
  • 7.2. Market Analysis - By Product Type
    • 7.2.1. Intraocular Lens
    • 7.2.2. Glaucoma Implants
    • 7.2.3. Ocular Prostheses
    • 7.2.4. Corneal Implants and Others
  • 7.3. Market Analysis - By End-user
    • 7.3.1. Hospitals
    • 7.3.2. Ophthalmic Clinics
    • 7.3.3. Others
  • 7.4. Market Analysis - By Country
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Ocular Implants Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Key Findings / Summary
  • 8.2. Market Analysis - By Product Type
    • 8.2.1. Intraocular Lens
    • 8.2.2. Glaucoma Implants
    • 8.2.3. Ocular Prostheses
    • 8.2.4. Corneal Implants and Others
  • 8.3. Market Analysis - By End-user
    • 8.3.1. Hospitals
    • 8.3.2. Ophthalmic Clinics
    • 8.3.3. Others
  • 8.4. Market Analysis - By Country
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Ocular Implants Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Key Findings / Summary
  • 9.2. Market Analysis - By Product Type
    • 9.2.1. Intraocular Lens
    • 9.2.2. Glaucoma Implants
    • 9.2.3. Ocular Prostheses
    • 9.2.4. Corneal Implants and Others
  • 9.3. Market Analysis - By End-user
    • 9.3.1. Hospitals
    • 9.3.2. Ophthalmic Clinics
    • 9.3.3. Others
  • 9.4. Market Analysis - By Country
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Ocular Implants Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Key Findings / Summary
  • 10.2. Market Analysis - By Product Type
    • 10.2.1. Intraocular Lens
    • 10.2.2. Glaucoma Implants
    • 10.2.3. Ocular Prostheses
    • 10.2.4. Corneal Implants and Others
  • 10.3. Market Analysis - By End-user
    • 10.3.1. Hospitals
    • 10.3.2. Ophthalmic Clinics
    • 10.3.3. Others
  • 10.4. Market Analysis - By Country
    • 10.4.1. GCC Countries
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Key Industry Developments
  • 11.2. Global Market Share Analysis (2025)
  • 11.3. Competition Dashboard
  • 11.4. Comparative Analysis - Major Players
  • 11.5. Company Profiles
    • 11.5.1. Alcon
      • 11.5.1.1. Overview,
      • 11.5.1.2. Products & services,
      • 11.5.1.3. SWOT analysis,
      • 11.5.1.4. Recent developments,
      • 11.5.1.5. strategies,
      • 11.5.1.6. financials (based on availability)
    • 11.5.2. Johnson and Johnson Services, Inc.
      • 11.5.2.1. Overview,
      • 11.5.2.2. Products & services,
      • 11.5.2.3. SWOT analysis,
      • 11.5.2.4. Recent developments,
      • 11.5.2.5. strategies,
      • 11.5.2.6. financials (based on availability)
    • 11.5.3. Bausch & Lomb Incorporated
      • 11.5.3.1. Overview,
      • 11.5.3.2. Products & services,
      • 11.5.3.3. SWOT analysis,
      • 11.5.3.4. Recent developments,
      • 11.5.3.5. strategies,
      • 11.5.3.6. financials (based on availability)
    • 11.5.4. ZEISS International
      • 11.5.4.1. Overview,
      • 11.5.4.2. Products & services,
      • 11.5.4.3. SWOT analysis,
      • 11.5.4.4. Recent developments,
      • 11.5.4.5. strategies,
      • 11.5.4.6. financials (based on availability)
    • 11.5.5. STAAR SURGICAL
      • 11.5.5.1. Overview,
      • 11.5.5.2. Products & services,
      • 11.5.5.3. SWOT analysis,
      • 11.5.5.4. Recent developments,
      • 11.5.5.5. strategies,
      • 11.5.5.6. financials (based on availability)
    • 11.5.6. Hoya Corporation
      • 11.5.6.1. Overview,
      • 11.5.6.2. Products & services,
      • 11.5.6.3. SWOT analysis,
      • 11.5.6.4. Recent developments,
      • 11.5.6.5. strategies,
      • 11.5.6.6. financials (based on availability)
    • 11.5.7. Glaukos
      • 11.5.7.1. Overview,
      • 11.5.7.2. Products & services,
      • 11.5.7.3. SWOT analysis,
      • 11.5.7.4. Recent developments,
      • 11.5.7.5. strategies,
      • 11.5.7.6. financials (based on availability)
    • 11.5.8. Second Sight
      • 11.5.8.1. Overview,
      • 11.5.8.2. Products & services,
      • 11.5.8.3. SWOT analysis,
      • 11.5.8.4. Recent developments,
      • 11.5.8.5. strategies,
      • 11.5.8.6. financials (based on availability)
    • 11.5.9. Allergan
      • 11.5.9.1. Overview,
      • 11.5.9.2. Products & services,
      • 11.5.9.3. SWOT analysis,
      • 11.5.9.4. Recent developments,
      • 11.5.9.5. strategies,
      • 11.5.9.6. financials (based on availability)
    • 11.5.10. Other Prominent Players
      • 11.5.10.1. Overview,
      • 11.5.10.2. Products & services,
      • 11.5.10.3. SWOT analysis,
      • 11.5.10.4. Recent developments,
      • 11.5.10.5. strategies,
      • 11.5.10.6. financials (based on availability)

12. Strategic Recommendations

List of Tables

  • Table 1: Global Ocular Implants Market Revenue (US$ Mn) Forecast, by Product Type, 2021-2034
  • Table 2: Global Ocular Implants Market Revenue (US$ Mn) Forecast, by End-user, 2021-2034
  • Table 3: Global Ocular Implants Market Revenue (US$ Mn) Forecast, by Region, 2021-2034
  • Table 4: North America Ocular Implants Market Revenue (US$ Mn) Forecast, by Product Type, 2021-2034
  • Table 5: North America Ocular Implants Market Revenue (US$ Mn) Forecast, by End-user, 2021-2034
  • Table 6: North America Ocular Implants Market Revenue (US$ Mn) Forecast, By Country, 2021-2034
  • Table 7: Europe Ocular Implants Market Revenue (US$ Mn) Forecast, by Product Type, 2021-2034
  • Table 8: Europe Ocular Implants Market Revenue (US$ Mn) Forecast, by End-user, 2021-2034
  • Table 9: Europe Ocular Implants Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034
  • Table 10: Asia Pacific Ocular Implants Market Revenue (US$ Mn) Forecast, by Product Type, 2021-2034
  • Table 11: Asia Pacific Ocular Implants Market Revenue (US$ Mn) Forecast, by End-user, 2021-2034
  • Table 12: Asia Pacific Ocular Implants Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Latin America Ocular Implants Market Revenue (US$ Mn) Forecast, by Product Type, 2021-2034
  • Table 14: Latin America Ocular Implants Market Revenue (US$ Mn) Forecast, by End-user, 2021-2034
  • Table 15: Latin America Ocular Implants Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Middle East & Africa Ocular Implants Market Revenue (US$ Mn) Forecast, by Product Type, 2021-2034
  • Table 17: Middle East & Africa Ocular Implants Market Revenue (US$ Mn) Forecast, by End-user, 2021-2034
  • Table 18: Middle East & Africa Ocular Implants Market Revenue (US$ Mn) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Ocular Implants Market Revenue Breakdown (US$ Mn, %) by Region, 2025 & 2034
  • Figure 2: Global Ocular Implants Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 3: Global Ocular Implants Market Forecast (US$ Mn), by Intraocular Lens, 2025-2034
  • Figure 4: Global Ocular Implants Market Forecast (US$ Mn), by Glaucoma Implants, 2025-2034
  • Figure 5: Global Ocular Implants Market Forecast (US$ Mn), by Ocular Prostheses, 2025-2034
  • Figure 6: Global Ocular Implants Market Forecast (US$ Mn), by Corneal Implants and Others, 2025-2034
  • Figure 7: Global Ocular Implants Market Forecast (US$ Mn), by Pro5, 2025-2034
  • Figure 8: Global Ocular Implants Market Value Share (%), by End-user, 2025 & 2034
  • Figure 9: Global Ocular Implants Market Forecast (US$ Mn), by Hospitals, 2025-2034
  • Figure 10: Global Ocular Implants Market Forecast (US$ Mn), by Ophthalmic Clinics, 2025-2034
  • Figure 11: Global Ocular Implants Market Forecast (US$ Mn), by Others, 2025-2034
  • Figure 12: Global Ocular Implants Market Value (US$ Mn), by Region, 2025 & 2034
  • Figure 13: North America Ocular Implants Market Value (US$ Mn), by Product Type, 2025 & 2034
  • Figure 14: North America Ocular Implants Market Value Share (%), by Product Type, 2025
  • Figure 15: North America Ocular Implants Market Value (US$ Mn), by End-user, 2025 & 2034
  • Figure 16: North America Ocular Implants Market Value Share (%), by End-user, 2025
  • Figure 17: North America Ocular Implants Market Value (US$ Mn), By Country, 2025 & 2034
  • Figure 18: North America Ocular Implants Market Value Share (%), By Country, 2025
  • Figure 19: Europe Ocular Implants Market Value (US$ Mn), by Product Type, 2025 & 2034
  • Figure 20: Europe Ocular Implants Market Value Share (%), by Product Type, 2025
  • Figure 21: Europe Ocular Implants Market Value (US$ Mn), by End-user, 2025 & 2034
  • Figure 22: Europe Ocular Implants Market Value Share (%), by End-user, 2025
  • Figure 23: Europe Ocular Implants Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034
  • Figure 24: Europe Ocular Implants Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 25: Asia Pacific Ocular Implants Market Value (US$ Mn), by Product Type, 2025 & 2034
  • Figure 26: Asia Pacific Ocular Implants Market Value Share (%), by Product Type, 2025
  • Figure 27: Asia Pacific Ocular Implants Market Value (US$ Mn), by End-user, 2025 & 2034
  • Figure 28: Asia Pacific Ocular Implants Market Value Share (%), by End-user, 2025
  • Figure 29: Asia Pacific Ocular Implants Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034
  • Figure 30: Asia Pacific Ocular Implants Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 31: Latin America Ocular Implants Market Value (US$ Mn), by Product Type, 2025 & 2034
  • Figure 32: Latin America Ocular Implants Market Value Share (%), by Product Type, 2025
  • Figure 33: Latin America Ocular Implants Market Value (US$ Mn), by End-user, 2025 & 2034
  • Figure 34: Latin America Ocular Implants Market Value Share (%), by End-user, 2025
  • Figure 35: Latin America Ocular Implants Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Latin America Ocular Implants Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Middle East & Africa Ocular Implants Market Value (US$ Mn), by Product Type, 2025 & 2034
  • Figure 38: Middle East & Africa Ocular Implants Market Value Share (%), by Product Type, 2025
  • Figure 39: Middle East & Africa Ocular Implants Market Value (US$ Mn), by End-user, 2025 & 2034
  • Figure 40: Middle East & Africa Ocular Implants Market Value Share (%), by End-user, 2025
  • Figure 41: Middle East & Africa Ocular Implants Market Value (US$ Mn), By Country/ Sub-region, 2025 & 2034
  • Figure 42: Middle East & Africa Ocular Implants Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 43: Global Ocular Implants Market Share (%), By Company, 2025